Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BERYL DRUGS vs S.S.ORGANICS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BERYL DRUGS S.S.ORGANICS BERYL DRUGS/
S.S.ORGANICS
 
P/E (TTM) x 49.3 12,223.0 0.4% View Chart
P/BV x 1.9 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BERYL DRUGS   S.S.ORGANICS
EQUITY SHARE DATA
    BERYL DRUGS
Mar-24
S.S.ORGANICS
Mar-23
BERYL DRUGS/
S.S.ORGANICS
5-Yr Chart
Click to enlarge
High Rs4541 111.0%   
Low Rs1221 55.5%   
Sales per share (Unadj.) Rs52.721.8 241.6%  
Earnings per share (Unadj.) Rs1.5-8.1 -18.6%  
Cash flow per share (Unadj.) Rs3.9-6.7 -57.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.6-32.5 -54.1%  
Shares outstanding (eoy) m5.0714.20 35.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.4 38.1%   
Avg P/E ratio x18.7-3.8 -494.8%  
P/CF ratio (eoy) x7.3-4.6 -158.9%  
Price / Book Value ratio x1.6-0.9 -170.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m144437 32.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1711 150.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m267310 86.3%  
Other income Rs m50 2,672.2%   
Total revenues Rs m272310 87.8%   
Gross profit Rs m22-79 -28.1%  
Depreciation Rs m1221 58.5%   
Interest Rs m515 31.9%   
Profit before tax Rs m10-114 -8.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m22 121.7%   
Profit after tax Rs m8-116 -6.6%  
Gross profit margin %8.2-25.3 -32.5%  
Effective tax rate %23.9-1.7 -1,369.1%   
Net profit margin %2.9-37.3 -7.7%  
BALANCE SHEET DATA
Current assets Rs m105250 42.2%   
Current liabilities Rs m61298 20.4%   
Net working cap to sales %16.7-15.5 -107.6%  
Current ratio x1.70.8 206.9%  
Inventory Days Days1416 85.8%  
Debtors Days Days1,036119,672,906 0.0%  
Net fixed assets Rs m72293 24.5%   
Share capital Rs m51142 35.9%   
"Free" reserves Rs m38-604 -6.3%   
Net worth Rs m89-462 -19.3%   
Long term debt Rs m24630 3.8%   
Total assets Rs m177543 32.6%  
Interest coverage x3.1-6.6 -47.1%   
Debt to equity ratio x0.3-1.4 -19.8%  
Sales to assets ratio x1.50.6 264.4%   
Return on assets %7.0-18.6 -37.8%  
Return on equity %8.625.0 34.4%  
Return on capital %13.1-58.8 -22.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m8-16 -50.2%  
From Investments Rs m-11-96 11.2%  
From Financial Activity Rs m1112 0.9%  
Net Cashflow Rs m-20 322.4%  

Share Holding

Indian Promoters % 26.4 53.3 49.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.6 46.7 157.6%  
Shareholders   7,364 10,154 72.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BERYL DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BERYL DRUGS vs S.S.ORGANICS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BERYL DRUGS vs S.S.ORGANICS Share Price Performance

Period BERYL DRUGS S.S.ORGANICS S&P BSE HEALTHCARE
1-Day 1.15% 2.63% 1.23%
1-Month -6.66% -27.57% -0.24%
1-Year 65.00% 124.48% 43.62%
3-Year CAGR 46.55% 41.80% 20.35%
5-Year CAGR 44.81% 50.02% 26.24%

* Compound Annual Growth Rate

Here are more details on the BERYL DRUGS share price and the S.S.ORGANICS share price.

Moving on to shareholding structures...

The promoters of BERYL DRUGS hold a 26.4% stake in the company. In case of S.S.ORGANICS the stake stands at 53.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BERYL DRUGS and the shareholding pattern of S.S.ORGANICS.

Finally, a word on dividends...

In the most recent financial year, BERYL DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

S.S.ORGANICS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BERYL DRUGS, and the dividend history of S.S.ORGANICS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.